Bridge Pharmaceuticals Raises $35M

San Francisco-based Bridge Pharmaceuticals has raised $35M in a Series B round, the firm said today. The funding came from existing investors along with Granite Gobal Ventures. Helen Wong of Granite Global has joined the firm's board of directors. Bridge Pharmaceuticals provides contract research operations for pharmaceutical firms, with operations in Gaithersburg, Maryland and Beijing, China. The firm is a spinoff of SRI. More information »